Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Molecular Cell
|
July 11, 1998
Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism
J D Leverson, S A Ness
The Journal of Biological Chemistry
|
June 22, 2000
The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7
H k Huang, C A Joazeiro, E Bonfoco, et al.
Molecular Biology of the Cell
|
July 11, 2000
The APC11 RING-H2 finger mediates E2-dependent ubiquitination
J D Leverson, C A Joazeiro, A M Page, et al.
Science (New York, N.Y.)
|
October 9, 1999
The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
C A Joazeiro, S S Wing, H Huang, et al.
Blood Cancer Journal
|
November 14, 2015
Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
D C Phillips, Y Xiao, L T Lam, et al.
Oncogene
|
December 7, 2010
Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines
H Zhang, S Guttikonda, L Roberts, et al.
Oncogene
|
March 6, 2007
Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition
E K-H Han, J D Leverson, T McGonigal, et al.
Molecular Cell
|
November 11, 1998
Pim-1 kinase and p100 cooperate to enhance c-Myb activity
J D Leverson, P J Koskinen, F C Orrico, et al.
Oncogene
|
October 26, 2005
RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors
S Morgan-Lappe, K W Woods, Q Li, et al.
British Journal of Pharmacology
|
May 26, 2012
Navitoclax (ABT-263) and bendamustine ± rituximab induce enhanced killing of non-Hodgkin's lymphoma tumours in vivo
S Ackler, M J Mitten, J Chen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Molecular Cell
|
July 11, 1998
Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism
J D Leverson, S A Ness
The Journal of Biological Chemistry
|
June 22, 2000
The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7
H k Huang, C A Joazeiro, E Bonfoco, et al.
Molecular Biology of the Cell
|
July 11, 2000
The APC11 RING-H2 finger mediates E2-dependent ubiquitination
J D Leverson, C A Joazeiro, A M Page, et al.
Science (New York, N.Y.)
|
October 9, 1999
The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
C A Joazeiro, S S Wing, H Huang, et al.
Blood Cancer Journal
|
November 14, 2015
Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
D C Phillips, Y Xiao, L T Lam, et al.
Oncogene
|
December 7, 2010
Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines
H Zhang, S Guttikonda, L Roberts, et al.
Oncogene
|
March 6, 2007
Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition
E K-H Han, J D Leverson, T McGonigal, et al.
Molecular Cell
|
November 11, 1998
Pim-1 kinase and p100 cooperate to enhance c-Myb activity
J D Leverson, P J Koskinen, F C Orrico, et al.
Oncogene
|
October 26, 2005
RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors
S Morgan-Lappe, K W Woods, Q Li, et al.
British Journal of Pharmacology
|
May 26, 2012
Navitoclax (ABT-263) and bendamustine ± rituximab induce enhanced killing of non-Hodgkin's lymphoma tumours in vivo
S Ackler, M J Mitten, J Chen, et al.
Page
of 2